Le Lézard
Classified in: Science and technology
Subjects: AWD, SVY

LivePerson named a Strong Performer in Digital Customer Interaction Solutions by leading independent research firm


Recognized as best fit for traditional enterprises seeking a reliable and scalable digital transformation partner

NEW YORK, June 27, 2024 /PRNewswire/ -- LivePerson (Nasdaq: LPSN), the enterprise leader in digital customer conversations, has been named a Strong Performer in "The Forrester Wavetm: Digital Customer Interaction Solutions, Q2 2024." According to the report, "LivePerson is the best fit for traditional enterprises seeking a reliable and scalable digital transformation partner."

The new report evaluates the 11 most significant providers of digital customer interaction solutions (DCIS) against 34 criteria to help contact center and digital business leaders select the right one for their needs.

LivePerson received the highest possible scores across 12 criteria: messaging engine, interaction quality evaluation, adaptive digital strategy optimization, accessibility, security and compliance, scalability and availability, adoption, pricing flexibility and transparency, partner ecosystem, community, revenue, and number of customers. According to the report, "LivePerson is equipped to meet the demands of even the most extensive enterprise messaging operations."

"Digital transformation is no small task, and enterprises are rightly concerned about finding a trusted partner to help them safely bridge the gap between the current state ? where call volumes and costs keep rising ? and the digital-first, AI-empowered contact center of the future. On top of multiple recognitions from Forrester over the past year, we're proud to be named among the top providers for digital customer interaction solutions," said John Sabino, CEO of LivePerson.

To learn more about LivePerson's solutions for digital customer conversations, visit www.liveperson.com.

About LivePerson
LivePerson (NASDAQ: LPSN) is the enterprise leader in digital customer conversations. The world's leading brands ? including HSBC, Chipotle, and Virgin Media ? use our award-winning Conversational Cloud platform to connect with millions of consumers. We power nearly a billion conversational interactions every month, providing a uniquely rich data set and AI-powered solutions to accelerate contact center transformation, supercharge agent productivity, and deliver more personalized customer experiences. Fast Company named us the #1 Most Innovative AI Company in the world. To talk with us or our AI, please visit liveperson.com.

Media contact:
Mike Tague
[email protected]

SOURCE LivePerson, Inc.


These press releases may also interest you

at 03:30
Amflow, the eMTB expert that builds e-bikes from heart to body, today marks its entry into the industry with the launch of the Amflow PL. Providing a significantly robust 850 W of peak power and weighing in at an industry leading level of ultra-light...

at 03:17
Daniels Manufacturing Corporation® (DMC®) is proud to announce the successful acquisition of MCD-Tools GmbH, a leading tool distribution and repair company based near Frankfurt, Germany. DMC's acquisition of MCD-Tools allows DMC to form DMC Europe...

at 03:05
NielsenIQ (NIQ) today announced the availability of NIQ Activate in the Microsoft Azure Marketplace, an online store providing applications and services for use on Azure. NIQ customers can now take advantage of the productive and trusted Azure cloud...

at 03:05
Owkin, the first end-to-end AI-biotech unicorn that provides best-in-class AI-driven precision drug discovery, development and diagnostics, has announced its expansion into the DACH region (Germany, Austria and Switzerland) following partnerships...

at 03:05
Manhattan Associates today announced that it has been named winner of the VIP Awards' Best Sustainability Initiative category for 2024. Selected from a competitive group of nominees, Manhattan Active® Supply Chain technology was chosen because of...

at 03:05
We are excited to share our latest development status. We are pleased to announce that the enrollment of patients in the Phase III clinical trial of DFP-14323 in combination with Afatinib (20 mg/day) versus Afatinib (40 mg/day) alone in stage...



News published on and distributed by: